This article describes the new and upcoming treatment options for rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, and gout to dissect what we should be aware of when discussing these new and promising molecules. PubMed, Immunol Res, 2014 Nov 9. (Also see: Biologic Agents)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.